Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region

Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region

Aim. To assess the survival and reasons for discontinuation of genetically engineered biological therapy (GEBT) in patients with inflammatory bowel disease (IBD) in the Chelyabinsk region. Materials and methods. In the period from 2014 to 2024, 249 patients with IBD in the Chelyabinsk region rece...

Full description

Saved in:
Bibliographic Details
Main Authors: Anastasia I. Dolgushina, Anna A. Saenko, Valerija V. Osaulenko, Alena S. Sluchanko, Guzel M. Khusainova, Ajman S. Sarsenbaeva, Elena Z. Novitskaya, Anna Yu. Zlakazova, Svetlana A. Merkulova, Aleksandr G. Vasilenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2025-01-01
Series:Терапевтический архив
Subjects:
persistence of biologic therapy
inflammatory bowel diseases
genetically engineered biological therapy
ulcerative colitis
crohn's disease
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/660916/194494
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items